Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX:APS), a clinical-stage precision oncology company developing a ...

Aptose Biosciences ( ($TSE:APS) ) has provided an announcement. On April 23, 2025, Aptose Biosciences announced that its current auditor, KPMG ...

Exceeded first quarter 2025 financial guidance across all key financial metrics; Delivered 8 percent organic constant currency revenue growth (7 percent reported) led by U.S. Fina ...

Robert Half Inc. today reported revenues and earnings for the first quarter ended March 31, 2025. For the three months ...

It appears that the flood gates have opened and that the IRS is finally processing and paying claims for the employee retention credit (ERC) en ...